Q3 2019 Holdings
Filed 2019-11-13 | 57 holdings | $322.4M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Glaxosmithkline PLCA | SPONSORED ADR | 37733W105 | $42.3M | 983,085 | 13.1% |
| Ensign Group Inc(ENSG)A | COM | 29358P101 | $27.8M | 586,674 | 8.6% |
| Danaher Corporation(DHR)A | COM | 235851102 | $25.8M | 178,704 | 8.0% |
| Zogenix IncA | COM NEW | 98978L204 | $25.8M | 643,818 | 8.0% |
| Ascendis Pharma A S(ASND)A | SPONSORED ADR | 04351P101 | $22.8M | 236,392 | 7.1% |
| Amarin Corp PLCA | SPONS ADR NEW | 023111206 | $20.2M | 1,329,695 | 6.3% |
| Sanofi(SNY)A | SPONSORED ADR | 80105N105 | $11.1M | 240,000 | 3.4% |
| Radius Health IncA | COM NEW | 750469207 | $8.9M | 344,698 | 2.8% |
| Envista Hldgs Corp(NVST)A | COM | 29415F104 | $8.9M | 318,000 | 2.8% |
| Vertex Pharmaceuticals Inc(VRTX)A | COM | 92532F100 | $8.6M | 50,909 | 2.7% |
| Illumina Inc(ILMN)A | COM | 452327109 | $8.1M | 26,750 | 2.5% |
| Alnylam Pharmaceuticals Inc(ALNY)A | COM | 02043Q107 | $7.4M | 92,040 | 2.3% |
| Audentes Therapeutics Inc(BOLDEUR)A | COM | 05070R104 | $7.1M | 253,726 | 2.2% |
| Dexcom Inc(DXCM)A | COM | 252131107 | $6.6M | 44,550 | 2.1% |
| R1 RCM IncA | COM | 749397105 | $6.5M | 725,972 | 2.0% |
| Abiomed Inc(ABMDEUR)A | COM | 003654100 | $5.3M | 29,950 | 1.7% |
| Omega Healthcare Invs Inc(OHI)A | COM | 681936100 | $4.5M | 106,500 | 1.4% |
| TG Therapeutics Inc(TGTX)A | COM | 88322Q108 | $4.3M | 773,501 | 1.3% |
| Oxford Immunotec Global PLCA | ORD SHS | G6855A103 | $4.3M | 256,000 | 1.3% |
| Teligent Inc NewA | COM | 87960W104 | $4.2M | 4,424,222 | 1.3% |
| Argenx SE(ARGX)A | SPONSORED ADR | 04016X101 | $4.1M | 36,004 | 1.3% |
| LTC Pptys Inc(LTC)A | COM | 502175102 | $3.6M | 69,327 | 1.1% |
| Sabra Health Care REIT Inc(SBRA)A | COM | 78573L106 | $3.5M | 154,100 | 1.1% |
| Model N Inc(MODNEUR)A | COM | 607525102 | $3.4M | 120,695 | 1.0% |
| Caretrust REIT Inc(CTRE)A | COM | 14174T107 | $3.3M | 137,464 | 1.0% |
| Biodelivery Sciences Intl in(BDSIUSD)A | COM | 09060J106 | $3.0M | 708,020 | 0.9% |
| Arqule Inc(ARQLUSD)A | COM | 04269E107 | $3.0M | 412,388 | 0.9% |
| Heska Corp(HSKAEUR)A | COM RESTRC NEW | 42805E306 | $2.9M | 40,824 | 0.9% |
| Ehealth Inc(EHTH)A | COM | 28238P109 | $2.8M | 42,653 | 0.9% |
| Amarin Corp PLCCallA | SPONS ADR NEW | 023111206 | $2.4M | 161,100 | 0.8% |
| Community Health SYS Inc New(CYH)A | COM | 203668108 | $2.2M | 607,383 | 0.7% |
| Fate Therapeutics Inc(FATE)A | COM | 31189P102 | $2.2M | 140,656 | 0.7% |
| Cytokinetics Inc(CYTK)A | COM NEW | 23282W605 | $2.1M | 181,700 | 0.6% |
| Tricida Inc(1T7)A | COM | 89610F101 | $2.0M | 65,568 | 0.6% |
| Macrogenics Inc(MGNX)A | COM | 556099109 | $2.0M | 154,824 | 0.6% |
| Xenon Pharmaceuticals Inc(XENE)A | COM | 98420N105 | $1.9M | 215,609 | 0.6% |
| Apellis Pharmaceuticals Inc(APLS)A | COM | 03753U106 | $1.9M | 79,509 | 0.6% |
| Biocryst Pharmaceuticals(BCRX)A | COM | 09058V103 | $1.9M | 654,460 | 0.6% |
| Collegium Pharmaceutical Inc(COLL)A | COM | 19459J104 | $1.8M | 160,295 | 0.6% |
| Scpharmaceuticals Inc(SCPH)A | COM | 810648105 | $1.3M | 221,636 | 0.4% |
| Agile Therapeutics Inc(AGRXUSD)A | COM | 00847L100 | $1.1M | 909,485 | 0.3% |
| Invacare CorpA | COM | 461203101 | $970.2K | 129,361 | 0.3% |
| Affimed N VA | COM | N01045108 | $947.2K | 322,171 | 0.3% |
| Otonomy IncA | COM | 68906L105 | $899.5K | 376,342 | 0.3% |
| Codexis Inc(CDXS)A | COM | 192005106 | $864.0K | 63,000 | 0.3% |
| Savara Inc(SVRA)A | COM | 805111101 | $839.2K | 316,679 | 0.3% |
| Deciphera Pharmaceuticals in(DCPHEUR)A | COM | 24344T101 | $746.7K | 22,000 | 0.2% |
| Optinose IncA | COM | 68404V100 | $735.7K | 105,106 | 0.2% |
| Eiger Biopharmaceuticals Inc(CLDNEUR)A | COM | 28249U105 | $714.5K | 69,708 | 0.2% |
| Dicerna Pharmaceuticals Inc(DRNAUSD)A | COM | 253031108 | $589.8K | 41,074 | 0.2% |